{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:08:34Z","timestamp":1776679714179,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00105-023-05197-4","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T12:02:15Z","timestamp":1692360135000},"page":"715-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rosazea\u00a0\u2013 die neue S2k-Leitlinie","Rosacea\u2014the updated S2k guideline"],"prefix":"10.1007","volume":"74","author":[{"given":"Anne-Charlotte","family":"Kuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Flaig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Guertler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"issue":"4","key":"5197_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1365-2133.2011.10436.x","volume":"165","author":"M Augustin","year":"2011","unstructured":"Augustin\u00a0M, Herberger\u00a0K, Hintzen\u00a0S, Heigel\u00a0H, Franzke\u00a0N, Schafer\u00a0I (2011) Prevalence of skin lesions and need for treatment in a\u00a0cohort of 90 880 workers. Br J Dermatol 165(4):865\u2013873","journal-title":"Br J Dermatol"},{"issue":"3","key":"5197_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/jdv.13556","volume":"30","author":"J Tan","year":"2016","unstructured":"Tan\u00a0J, Schofer\u00a0H, Araviiskaia\u00a0E et\u00a0al (2016) Prevalence of rosacea in the general population of Germany and Russia\u2014the RISE study. J\u00a0Eur Acad Dermatol Venereol 30(3):428\u2013434","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"5197_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.det.2017.11.013","volume":"36","author":"LA Cardwell","year":"2018","unstructured":"Cardwell\u00a0LA, Nyckowski\u00a0T, Uwakwe\u00a0LN, Feldman\u00a0SR (2018) Coping mechanisms and resources for patients suffering from rosacea. Dermatol Clin 36(2):171\u2013174","journal-title":"Dermatol Clin"},{"key":"5197_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/978-3-662-49544-5_71","volume-title":"Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie","author":"B Melnik","year":"2018","unstructured":"Melnik\u00a0B, Chen\u00a0W (2018) Akne und Rosazea. In: Plewig\u00a0G, Ruzicka\u00a0T, Kaufmann\u00a0R, Hertl\u00a0M (Hrsg) Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer, Berlin, Heidelberg, S 1305\u20131336"},{"issue":"5","key":"5197_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/bjd.18420","volume":"182","author":"M Schaller","year":"2020","unstructured":"Schaller\u00a0M, Almeida\u00a0LMC, Bewley\u00a0A et\u00a0al (2020) Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol 182(5):1269\u20131276","journal-title":"Br J Dermatol"},{"key":"5197_CR6","volume-title":"S2k-Leitlinie \u201eRosazea\u201c","author":"M Reinholz","year":"2022","unstructured":"Reinholz\u00a0M, Clanner-Engelshofen\u00a0BM, Bernhard\u00a0D et al (2022) S2k-Leitlinie \u201eRosazea\u201c (AWMF-Registernr. 013-065)"},{"issue":"2","key":"5197_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.optm.2010.01.015","volume":"82","author":"M Oltz","year":"2011","unstructured":"Oltz\u00a0M, Check\u00a0J (2011) Rosacea and its ocular manifestations. Optometry 82(2):92\u2013103","journal-title":"Optometry"},{"issue":"3","key":"5197_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones\u00a0L, Downie\u00a0LE, Korb\u00a0D et\u00a0al (2017) TFOS DEWS II management and therapy report. Ocul Surf 15(3):575\u2013628","journal-title":"Ocul Surf"},{"issue":"3","key":"5197_CR9","first-page":"544","volume":"8","author":"A Arman","year":"2015","unstructured":"Arman\u00a0A, Demirseren\u00a0DD, Takmaz\u00a0T (2015) Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline. Int J Ophthalmol 8(3):544\u2013549","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"5197_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/jdv.14402","volume":"31","author":"LI Gonser","year":"2017","unstructured":"Gonser\u00a0LI, Gonser\u00a0CE, Deuter\u00a0C, Heister\u00a0M, Zierhut\u00a0M, Schaller\u00a0M (2017) Systemic therapy of ocular and cutaneous rosacea in children. J\u00a0Eur Acad Dermatol Venereol 31(10):1732\u20131738","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"5197_CR11","first-page":"CD013697","volume":"6","author":"N Onghanseng","year":"2021","unstructured":"Onghanseng\u00a0N, Ng\u00a0SM, Halim\u00a0MS, Nguyen\u00a0QD (2021) Oral antibiotics for chronic blepharitis. Cochrane Database Syst Rev 6(6):CD13697","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5197_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjd.14930","volume":"176","author":"A Egeberg","year":"2017","unstructured":"Egeberg\u00a0A, Weinstock\u00a0LB, Thyssen\u00a0EP, Gislason\u00a0GH, Thyssen\u00a0JP (2017) Rosacea and gastrointestinal disorders: a\u00a0population-based cohort study. Br J Dermatol 176(1):100\u2013106","journal-title":"Br J Dermatol"},{"issue":"3","key":"5197_CR13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","volume":"22","author":"J Spoendlin","year":"2016","unstructured":"Spoendlin\u00a0J, Karatas\u00a0G, Furlano\u00a0RI, Jick\u00a0SS, Meier\u00a0CR (2016) Rosacea in patients with ulcerative colitis and Crohn\u2019s disease: a population-based case-control study. Inflamm Bowel Dis 22(3):680\u2013687","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"5197_CR14","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1111\/1346-8138.13985","volume":"44","author":"F Drago","year":"2017","unstructured":"Drago\u00a0F, Ciccarese\u00a0G, Parodi\u00a0A (2017) Effects of the treatment for small intestine bacterial overgrowth on rosacea. J\u00a0Dermatol 44(12):e321","journal-title":"J Dermatol"},{"issue":"9","key":"5197_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/1346-8138.13878","volume":"44","author":"P Saleh","year":"2017","unstructured":"Saleh\u00a0P, Naghavi-Behzad\u00a0M, Herizchi\u00a0H, Mokhtari\u00a0F, Mirza-Aghazadeh-Attari\u00a0M, Piri\u00a0R (2017) Effects of Helicobacter pylori treatment on rosacea: a single-arm clinical trial study. J\u00a0Dermatol 44(9):1033\u20131037","journal-title":"J Dermatol"},{"issue":"4","key":"5197_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/jid.2011.424","volume":"132","author":"M Sulk","year":"2012","unstructured":"Sulk\u00a0M, Seeliger\u00a0S, Aubert\u00a0J et al (2012) Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J\u00a0Invest Dermatol 132(4):1253\u20131262","journal-title":"J Invest Dermatol"},{"issue":"6","key":"5197_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2017.02.040","volume":"76","author":"S Li","year":"2017","unstructured":"Li\u00a0S, Cho\u00a0E, Drucker\u00a0AM, Qureshi\u00a0AA, Li\u00a0WQ (2017) Alcohol intake and risk of rosacea in US women. J\u00a0Am Acad Dermatol 76(6):1061\u20131067.e2","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5197_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/ddg.14683","volume":"20","author":"A Gurtler","year":"2022","unstructured":"Gurtler\u00a0A, Laurenz\u00a0S (2022) The impact of clinical nutrition on inflammatory skin diseases. J\u00a0Dtsch Dermatol Ges 20(2):185\u2013202","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"5197_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2340\/00015555-1976","volume":"95","author":"MM van der Linden","year":"2015","unstructured":"van der Linden\u00a0MM, van Rappard\u00a0DC, Daams\u00a0JG, Sprangers\u00a0MA, Spuls\u00a0PI, de Korte\u00a0J (2015) Health-related quality of life in patients with cutaneous rosacea: a\u00a0systematic review. Acta Derm Venereol 95(4):395\u2013400","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"5197_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","volume":"163","author":"B Aksoy","year":"2010","unstructured":"Aksoy\u00a0B, Altaykan-Hapa\u00a0A, Egemen\u00a0D, Karagoz\u00a0F, Atakan\u00a0N (2010) The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol 163(4):719\u2013725","journal-title":"Br J Dermatol"},{"issue":"1","key":"5197_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jdv.13748","volume":"31","author":"B Halioua","year":"2017","unstructured":"Halioua\u00a0B, Cribier\u00a0B, Frey\u00a0M, Tan\u00a0J (2017) Feelings of stigmatization in patients with rosacea. J\u00a0Eur Acad Dermatol Venereol 31(1):163\u2013168","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"5197_CR22","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/jdv.13305","volume":"29","author":"AM Layton","year":"2015","unstructured":"Layton\u00a0AM, Schaller\u00a0M, Homey\u00a0B et al (2015) Brimonidine gel 0.33\u202f% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a\u00a0randomized, double-blind, vehicle-controlled study. J\u00a0Eur Acad Dermatol Venereol 29(12):2405\u20132410","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"5197_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jaad.2014.08.027","volume":"72","author":"AM Two","year":"2015","unstructured":"Two\u00a0AM, Wu\u00a0W, Gallo\u00a0RL, Hata\u00a0TR (2015) Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J\u00a0Am Acad Dermatol 72(5):761\u2013770 (quiz 771\u2013762)","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"5197_CR24","first-page":"505","volume":"8","author":"H Gollnick","year":"2010","unstructured":"Gollnick\u00a0H, Blume-Peytavi\u00a0U, Szabo\u00a0EL et al (2010) Systemic isotretinoin in the treatment of rosacea\u2014doxycycline- and placebo-controlled, randomized clinical study. J\u00a0Dtsch Dermatol Ges 8(7):505\u2013515","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"5197_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1067\/mjd.2001.116219","volume":"45","author":"MV Dahl","year":"2001","unstructured":"Dahl\u00a0MV, Jarratt\u00a0M, Kaplan\u00a0D, Tuley\u00a0MR, Baker\u00a0MD (2001) Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J\u00a0Am Acad Dermatol 45(5):723\u2013730","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"5197_CR26","first-page":"s101","volume":"13","author":"JQ Del Rosso","year":"2014","unstructured":"Del Rosso\u00a0JQ, Kircik\u00a0LH (2014) Update on the management of rosacea: a\u00a0status report on the current role and new horizons with topical azelaic acid. J\u00a0Drugs Dermatol 13(12):s101\u2013107","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"5197_CR27","first-page":"4","volume":"14","author":"M Reinholz","year":"2016","unstructured":"Reinholz\u00a0M, Ruzicka\u00a0T, Steinhoff\u00a0M et al (2016) Pathogenesis and clinical presentation of rosacea as a\u00a0key for a\u00a0symptom-oriented therapy. J\u00a0Dtsch Dermatol Ges 14(6):4\u201315","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"5197_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jaad.2018.01.027","volume":"78","author":"ZD Draelos","year":"2018","unstructured":"Draelos\u00a0ZD, Gold\u00a0MH, Weiss\u00a0RA et al (2018) Efficacy and safety of oxymetazoline cream 1.0\u202f% for treatment of persistent facial erythema associated with rosacea: findings from the 52-week open label REVEAL trial. J\u00a0Am Acad Dermatol 78(6):1156\u20131163","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5197_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/11204850-000000000-00000","volume":"11","author":"K McKeage","year":"2010","unstructured":"McKeage\u00a0K, Deeks\u00a0ED (2010) Doxycycline 40\u202fmg capsules (30\u202fmg immediate-release\/10\u202fmg delayed-release beads): anti-inflammatory dose in rosacea. Am J Clin Dermatol 11(3):217\u2013222","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"5197_CR30","first-page":"904","volume":"9","author":"I Pfeffer","year":"2011","unstructured":"Pfeffer\u00a0I, Borelli\u00a0C, Zierhut\u00a0M, Schaller\u00a0M (2011) Treatment of ocular rosacea with 40\u202fmg doxycycline in a\u00a0slow release form. J\u00a0Dtsch Dermatol Ges 9(11):904\u2013907","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"5197_CR31","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-4362.1986.tb04533.x","volume":"25","author":"E Hoting","year":"1986","unstructured":"Hoting\u00a0E, Paul\u00a0E, Plewig\u00a0G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25(10):660\u2013663","journal-title":"Int J Dermatol"},{"issue":"3","key":"5197_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","volume":"67","author":"CC Hsu","year":"2012","unstructured":"Hsu\u00a0CC, Lee\u00a0JY (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a\u00a0nonselective beta-adrenergic blocker. J\u00a0Am Acad Dermatol 67(3):491\u2013493","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"5197_CR33","first-page":"838","volume":"11","author":"ND Bhatia","year":"2012","unstructured":"Bhatia\u00a0ND, Del Rosso\u00a0JQ (2012) Optimal management of papulopustular rosacea: rationale for combination therapy. J\u00a0Drugs Dermatol 11(7):838\u2013844","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"5197_CR34","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1610-0387.2007.06513.x","volume":"5","author":"F Bahmer","year":"2007","unstructured":"Bahmer\u00a0F, Drosner\u00a0M, Hohenleutner\u00a0U et\u00a0al (2007) Recommendation for laser and intense pulsed light (IPL) therapy in dermatology. J\u00a0Dtsch Dermatol Ges 5(11):1036\u20131042","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"5197_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s00266-004-0012-x","volume":"28","author":"PK Goon","year":"2004","unstructured":"Goon\u00a0PK, Dalal\u00a0M, Peart\u00a0FC (2004) The gold standard for decortication of rhinophyma: combined erbium-YAG\/CO2 laser. Aesthetic Plast Surg 28(6):456\u2013460","journal-title":"Aesthetic Plast Surg"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05197-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T14:03:50Z","timestamp":1693922630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05197-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5197"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05197-4","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"29 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.-C.\u00a0Kuna<\/b>: A.\u00a0Finanzielle Interessen: A.-C.\u00a0Kuna gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Klinik und Poliklinik f\u00fcr Dermatologie und Allergologie, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Frauenlobstr. 9\u201311, 80337 M\u00fcnchen | Mitgliedschaft: Deutsche Dermatologische Gesellschaft. <b>M.J.\u00a0Flaig<\/b>: A.\u00a0Finanzielle Interessen: M.J.\u00a0Flaig gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Stellvertretender Direktor, Klinik und Poliklinik f\u00fcr Dermatologie und Allergologie, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Frauenlobstr. 9\u201311, 80337 M\u00fcnchen.  <b>A.\u00a0Guertler<\/b>: A.\u00a0Finanzielle Interessen: A.\u00a0G\u00fcrtler gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Fach\u00e4rztin f\u00fcr Dermatologie, Klinik und Poliklinik f\u00fcr Dermatologie und Allergologie, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Frauenlobstr. 9\u201311, 80337 M\u00fcnchen  | Mitgliedschaften: DDG, DGDC, DGE, ESPEN.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}